Government of Canada signs bilateral agreement with Alberta to improve access to drugs for rare diseases

News Healthcare & Pharma General Updates

Date: 5th Dec, 2024 Source: Health Canada Country: Canada Original Source

Brief

On December 5, 2024, Health Canada announced a bilateral agreement with Alberta to improve access to selected new drugs for rare diseases. The $162 million investment aims to provide timely access to quality health services and medications for Canadians living with rare diseases. The initial step of this agreement involves delivering funding to support three specific drugs: Poteligeo, Oxlumo, and Epkinly, under the National Strategy for Drugs for Rare Diseases.

This content is restricted.

Highlights content goes here...

This content is restricted.

Health Canada

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Government of Canada signs bilateral agreement with Alberta to improve access to drugs for rare diseases

Brief

Health Canada

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Government of Canada signs bilateral agreement with Alberta to improve access to drugs for rare diseases

Brief

Health Canada

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.